Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karina A Pasquevich

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
International Journal of Medical Microbiology : IJMM|July 7, 2021
Systemic bacterial infections affect dendritic cell development and functionKristin Bieber, Manina Günter, Karina A Pasquevich, et al.
Journal of Pharmaceutical Sciences|October 15, 2020
Stability Studies of the Vaccine Adjuvant U-Omp19M Laura Darriba, María L Cerutti, Laura Bruno, et al.
Vaccine|June 16, 2020
U-Omp19 from Brucella abortus increases dmLT immunogenicity and improves protection against Escherichia coli heat-labile toxin (LT) oral challengeLorena M Coria, Franco L Martinez, Laura A Bruno, et al.
Frontiers in Immunology|November 19, 2025
Discovery of protease inhibitors from bacteria as novel adjuvants for oral vaccine formulationsLorena M Coria, Celeste Pueblas Castro, Laura Bruno, et al.
Frontiers in Immunology|November 19, 2025
Correction: Discovery of protease inhibitors from bacteria as novel adjuvants for oral vaccine formulationsLorena M Coria, Celeste Pueblas Castro, Laura Bruno, et al.
Microbes and Infection|April 21, 2009
Brucella abortus activates human neutrophilsAstrid Zwerdling, M Victoria Delpino, Karina A Pasquevich, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 30, 2018
Oral co-administration of a bacterial protease inhibitor in the vaccine formulation increases antigen delivery at the intestinal epithelial barrierLorena M Coria, Gabriela S Risso, Francisco F Guaimas, et al.
Vaccine|December 29, 2015
Brucella abortus Omp19 recombinant protein subcutaneously co-delivered with an antigen enhances antigen-specific T helper 1 memory responses and induces protection against parasite challengeLorena M Coria, Andrés E Ibañez, Karina A Pasquevich, et al.
Microbes and Infection|September 2, 2008
Brucella lipoproteins mimic dendritic cell maturation induced by Brucella abortusAstrid Zwerdling, M Victoria Delpino, Paula Barrionuevo, et al.
Infection and Immunity|November 22, 2005
Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infectionJuliana Cassataro, Silvia M Estein, Karina A Pasquevich, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
International Journal of Medical Microbiology : IJMM|July 7, 2021
Systemic bacterial infections affect dendritic cell development and functionKristin Bieber, Manina Günter, Karina A Pasquevich, et al.
Journal of Pharmaceutical Sciences|October 15, 2020
Stability Studies of the Vaccine Adjuvant U-Omp19M Laura Darriba, María L Cerutti, Laura Bruno, et al.
Vaccine|June 16, 2020
U-Omp19 from Brucella abortus increases dmLT immunogenicity and improves protection against Escherichia coli heat-labile toxin (LT) oral challengeLorena M Coria, Franco L Martinez, Laura A Bruno, et al.
Frontiers in Immunology|November 19, 2025
Discovery of protease inhibitors from bacteria as novel adjuvants for oral vaccine formulationsLorena M Coria, Celeste Pueblas Castro, Laura Bruno, et al.
Frontiers in Immunology|November 19, 2025
Correction: Discovery of protease inhibitors from bacteria as novel adjuvants for oral vaccine formulationsLorena M Coria, Celeste Pueblas Castro, Laura Bruno, et al.
Microbes and Infection|April 21, 2009
Brucella abortus activates human neutrophilsAstrid Zwerdling, M Victoria Delpino, Karina A Pasquevich, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 30, 2018
Oral co-administration of a bacterial protease inhibitor in the vaccine formulation increases antigen delivery at the intestinal epithelial barrierLorena M Coria, Gabriela S Risso, Francisco F Guaimas, et al.
Vaccine|December 29, 2015
Brucella abortus Omp19 recombinant protein subcutaneously co-delivered with an antigen enhances antigen-specific T helper 1 memory responses and induces protection against parasite challengeLorena M Coria, Andrés E Ibañez, Karina A Pasquevich, et al.
Microbes and Infection|September 2, 2008
Brucella lipoproteins mimic dendritic cell maturation induced by Brucella abortusAstrid Zwerdling, M Victoria Delpino, Paula Barrionuevo, et al.
Infection and Immunity|November 22, 2005
Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infectionJuliana Cassataro, Silvia M Estein, Karina A Pasquevich, et al.
Pageof 4